Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Herbert Irving Comprehensive Cancer Center | Researchclopedia

Back to institutions

Herbert Irving Comprehensive Cancer Center

New Yorkhealthcare

783

Works

100,681

Citations

131

h-index

Top Research Topics

Cancer Immunotherapy and Biomarkers Endometrial and Cervical Cancer Treatments Prostate Cancer Treatment and Research

Top Researchers

Brent R. Stockwell Columbia University

324 works121,558 citationsh-index: 103

Recent Research

Perturbation-guided mapping of colorectal cancer cell states to causal mechanisms

Soroor Hediyeh-zadeh,Tzen S. Toh,et al.

20260 citations

Ovarian cancer diagnosis and treatment

Cancer Genomics and Diagnostics

CAR-T cell therapy research

Glioma Diagnosis and Treatment

Pancreatic and Hepatic Oncology Research

Lymphoma Diagnosis and Treatment

Uterine Myomas and Treatments

Epigenetics and DNA Methylation

Immunotherapy and Immune Responses

Carlos Cordon‐Cardo Mount Sinai Hospital

935 works97,481 citationsh-index: 154

Guy M. McKhann Columbia University

807 works95,020 citationsh-index: 111

Timothy C. Wang

1,158 works90,972 citationsh-index: 128

Charles G. Drake Johnson & Johnson (United States)

1,172 works90,383 citationsh-index: 133

Sandro Galea Washington University in St. Louis

1,972 works89,021 citationsh-index: 143

DB-1311/BNT324 (a novel B7H3 ADC) in patients with heavily pretreated mCRPC from a phase 1/2 study: Analyses according to prior treatment with lutetium 177 (177Lu)-PSMA-617.

Mark N. Stein,Andrew Parsonson,et al.

20260 citations

Cyto-KIK: A phase II trial of cytoreductive surgery in kidney cancer plus immunotherapy (nivolumab) and targeted kinase inhibition (cabozantinib).

Karie Runcie,Moshe C. Ornstein,et al.

20260 citations

A phase 1/2 study of MRT-2359, a highly selective oral GSPT1 molecular glue degrader (MGD), in combination with enzalutamide in metastatic castration-resistant prostate cancer (mCRPC) harboring AR ligand binding domain (LBD) mutations.

Rahul Atul Parikh,Benjamin Herzberg,et al.

20260 citations

A modular transcript enrichment strategy for scalable, atlas-aligned, and clonotype-resolved single-cell transcriptomics

Mathini Vaikunthan,Anna C. M. Schoonen,et al.

20260 citations

Clinical Outcomes of Lisocabtagene Maraleucel (liso-cel) in Younger Patients (Pts) with Relapsed or Refractory (R/R) Large B-cell Lymphoma (LBCL)

Irtiza Sheikh,Krish Patel,et al.

20260 citations